In the Severance cohort, we analyzed 96 patients with GBM, categorizing them into two groups based on C5aR1 expression levels: C5aR1 High (n = 61) and C5aR1 Low (n = 35) (Fig. 1a). Here, C5AR1 is linked to glioblastoma.